Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willis H Navarro

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
JAMA|August 5, 2010
Donor policies for stem cell transplantationWillis H Navarro
Leukemia & Lymphoma|September 3, 2010
Obesity and lymphoma therapy: not a bad combination after allWillis H Navarro, Fausto R Loberiza
Blood|August 16, 2005
AIDS-related lymphoproliferative diseaseWillis H Navarro, Lawrence D Kaplan
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2012
National marrow donor program session: donor issuesWillis H Navarro, Galen E Switzer, Michael Pulsipher
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantationWillis H Navarro, Fausto R Loberiza, Ruta Bajorunaite, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2005
Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minoritiesChristopher J Schwake, Mary Eapen, Stephanie J Lee, et al.
British Journal of Haematology|October 2, 2014
Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasiaJuliet N Barker, Mingwei Fei, Chatchada Karanes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid TumorsJessica J Tao, Nicholas A Cangemi, Vicky Makker, et al.
Blood|April 17, 2014
Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donationMichael A Pulsipher, Pintip Chitphakdithai, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantationFausto R Loberiza, Stephanie J Lee, Cesar O Freytes, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
JAMA|August 5, 2010
Donor policies for stem cell transplantationWillis H Navarro
Leukemia & Lymphoma|September 3, 2010
Obesity and lymphoma therapy: not a bad combination after allWillis H Navarro, Fausto R Loberiza
Blood|August 16, 2005
AIDS-related lymphoproliferative diseaseWillis H Navarro, Lawrence D Kaplan
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2012
National marrow donor program session: donor issuesWillis H Navarro, Galen E Switzer, Michael Pulsipher
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantationWillis H Navarro, Fausto R Loberiza, Ruta Bajorunaite, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2005
Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minoritiesChristopher J Schwake, Mary Eapen, Stephanie J Lee, et al.
British Journal of Haematology|October 2, 2014
Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasiaJuliet N Barker, Mingwei Fei, Chatchada Karanes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid TumorsJessica J Tao, Nicholas A Cangemi, Vicky Makker, et al.
Blood|April 17, 2014
Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donationMichael A Pulsipher, Pintip Chitphakdithai, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantationFausto R Loberiza, Stephanie J Lee, Cesar O Freytes, et al.
Pageof 3